iShares Genomics Immunology and Healthcare ETF Rating $22.48 +0.57 (+2.60%) As of 01/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.78Holdings in IDNA have an aggregate rating of Moderate Buy based on 410 analyst ratings issued in the past year covering 40 companies (68.5% of the portfolio).IDNA Aggregate Price Target$22.48High Prediction$22.48Average Prediction$22.48Low Prediction$22.48Holdings in IDNA have an aggregate price target of $22.48 and a range of $22.48 to $22.48 covering 40 companies (68.5% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.19%MRKMerck & Co., Inc.$96.18-1.8%4.9993 of 5 stars2.67$123.00 27.9%21Analyst ForecastAnalyst RevisionNews CoveragePositive NewsHigh Trading Volume4.13%EXELExelixis$36.43+0.6%4.6946 of 5 stars2.53$35.50 -2.6%194.07%ACLXArcellx$66.57+0.1%3.29 of 5 stars3.13$105.93 59.1%15Short Interest ↑Analyst Revision4.06%BNTXBioNTech$117.25+4.8%1.7569 of 5 stars2.88$142.72 21.7%173.97%REGNRegeneron Pharmaceuticals$687.80+0.9%4.6189 of 5 stars2.65$1,015.38 47.6%23Analyst Revision3.96%INCYIncyte$73.47+2.1%4.7901 of 5 stars2.35$76.29 3.8%20Analyst Revision3.95%RVMDRevolution Medicines$40.16-0.3%4.474 of 5 stars3.08$66.25 65.0%123.89%MRNAModerna$35.89+5.4%4.7935 of 5 stars2.13$75.58 110.6%23Gap Up3.88%TWSTTwist Bioscience$50.45+6.1%2.9033 of 5 stars2.70$51.90 2.9%103.55%JANXJanux Therapeutics$40.91+0.5%3.5205 of 5 stars3.08$89.90 119.8%13Analyst Revision3.49%SWTXSpringWorks Therapeutics$36.35+5.0%1.4906 of 5 stars3.00$70.00 92.6%62.80%GERNGeron$2.96+2.4%3.7274 of 5 stars3.09$7.25 144.9%11Gap Up2.58%IOVAIovance Biotherapeutics$5.88-0.5%4.1513 of 5 stars2.88$23.00 291.2%82.28%XNCRXencor$20.45+6.3%4.1191 of 5 stars3.13$34.88 70.5%82.08%BCRXBioCryst Pharmaceuticals$7.61+2.1%4.3516 of 5 stars2.83$15.17 99.3%61.77%NVAXNovavax$8.81+4.9%4.0334 of 5 stars2.33$17.83 102.4%61.05%RCUSArcus Biosciences$14.11+0.6%2.0324 of 5 stars3.00$34.00 141.0%9Analyst RevisionNews Coverage0.93%VIRVir Biotechnology$10.42+3.1%4.207 of 5 stars2.83$34.83 234.3%6Positive News0.93%PSTXPoseida Therapeutics$9.503.2323 of 5 stars2.00$9.50 0.0%50.91%ABCLAbCellera Biologics$3.06+3.0%2.7739 of 5 stars2.67$8.33 172.3%30.81%KURAKura Oncology$7.39+1.8%4.4702 of 5 stars2.91$27.38 270.4%11Analyst RevisionHigh Trading Volume0.76%IMNMImmunome$10.17+1.8%1.5071 of 5 stars3.00$28.83 183.5%70.71%MREOMereo BioPharma Group$2.99+4.5%1.9748 of 5 stars3.43$7.83 162.0%7Gap Down0.68%SGMOSangamo Therapeutics$1.13+3.7%2.8124 of 5 stars2.67$5.50 386.7%60.64%CRGXCARGO Therapeutics$12.86+3.8%1.5776 of 5 stars3.00$31.80 147.3%60.63%IBRXImmunityBio$3.22+9.5%2.3941 of 5 stars3.00$13.58 321.8%40.63%PACBPacific Biosciences of California$1.70+3.7%1.9078 of 5 stars2.50$2.95 73.8%12Analyst Revision0.60%ARCTArcturus Therapeutics$16.41-2.3%2.5039 of 5 stars3.14$66.75 306.8%7Short Interest ↑Positive News0.59%CELCCelcuity$11.21+2.6%2.5377 of 5 stars3.14$29.17 160.2%7Positive News0.51%VERVVerve Therapeutics$6.57+7.0%2.7444 of 5 stars3.00$25.75 291.9%4Analyst RevisionHigh Trading Volume0.50%OABIOmniAb$3.22+0.3%2.3043 of 5 stars3.00$9.00 179.5%4Positive NewsHigh Trading Volume0.50%ORICORIC Pharmaceuticals$10.00+4.4%3.7366 of 5 stars3.00$18.29 82.9%80.50%DNAGinkgo Bioworks$11.55+6.6%0.6542 of 5 stars1.60$4.58 -60.4%50.43%ALLOAllogene Therapeutics$1.84+1.1%2.5839 of 5 stars2.90$9.73 429.0%100.41%RIGLRigel Pharmaceuticals$21.81+8.3%4.1689 of 5 stars2.40$36.20 66.0%5Analyst Revision0.31%CRSPCRISPR Therapeutics$41.51+2.4%2.5057 of 5 stars2.47$78.38 88.8%19Short Interest ↑Analyst RevisionGap Up0.30%FDMT4D Molecular Therapeutics$4.67+2.0%3.4968 of 5 stars2.64$38.56 725.6%11Analyst RevisionNews Coverage0.19%LGNDLigand Pharmaceuticals$117.36+4.9%4.9505 of 5 stars3.00$147.00 25.3%60.18%BEAMBeam Therapeutics$24.53+4.7%3.5098 of 5 stars2.92$47.67 94.3%120.11%NTLAIntellia Therapeutics$9.94+4.6%4.657 of 5 stars2.72$51.06 413.7%18 This page (NYSEARCA:IDNA) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDNA Stock Alerts